One of the top drug manufacturers, Merck & Co. Inc., released quarterly earnings last Friday that beat analyst’s expectations. The Company posted fourth-quarter earnings excluding items of 83 cents per share and revenue of $11.7 billion. Analysts had expected the company to report earnings excluding items of 81 cents a share on $11.49 billion in revenue. Shares dropped 3.28% on Friday after the Company also said it would delay seeking approval until next year for their high profile osteoporosis drug.For up to date coverage on the hottest stocks in today’s markets, sign up to receive our free newsletters at: http://www.stockpublisher.comZoetis Inc. (NYSE: ZTS) - Zoetis Inc. made its big debut this past Friday on the NYSE. It gained 19.27% on Friday closing at $31.01 a share. The company is pharmaceutical giant Pfizer Inc’s animal-health division, and has a 60-year history under Pfizer. Pfizer holds an 83% stake in the unit. ZTS’s IPO on Friday was the biggest one made since Facebook Inc., with 86.1 million shares offered, raising $2.24 billion. Zoetis makes vaccines for both farm and companion animals, and has operations in about 70 countries worldwide. Zoetis reported revenues of $4.2 billion in 2011 and $3.2 billion through the first nine months of last year. ZTS is the largest animal- health business, with $4.3 billion sales in 2012 -- about 20 percent of the $22 billion market.Life Time Fitness Inc. (NYSE: LTM) – Shares of Life Time Fitness fell hard on Friday, to levels not seen since it’s market debut back in 2004. On Friday LTM closed down $11.37 or 22.41%. The stock hit a new 52-week low of $39.10 that day and slightly bounced back to close at $39.36. Volume traded at 8,526,759 was nearly twenty times higher than average volume of 442,065. Life Time Fitness issued weak preliminary results for 2012 expecting earnings between $2.63 and $2.66 per share for the full year 2012, on revenue of roughly $1.13 billion. Analysts, on average, were expecting earnings of $2.69 per share on revenue of $1.13 billion. For 2013, the Company forecast earnings between $2.85 and $2.95 per share, on revenue of $1.20 billion to $1.22 billion. Wall Street was expecting earnings of $2.98 per share on revenue of $1.21 billion. Shares on Friday fell to their lowest point in over a year.Brightcove, Inc. (Nasdaq: BCOV) – BCOV shares saw a big drop on Friday closing down $2.31 or 27.43% after the stock was downgraded by research firm RBC Capital Mkts. The Company announced strong earnings late Thursday. Fourth quarter revenue was$24.3 million, up 31% year-over-year while fiscal year 2012 revenue was $88.0 million, up 38% year-over-year. Brightcove Inc. CEO Jeremy Allaire announced hewill step down and COO David Mendel will take his place. Mendel was former senior vice president and general manager of Adobe’s Business Productivity Unit. Volume traded on Friday was significantly higher at 4,842,989 in comparison to a daily average of 449,476. On Friday shares also hit a new 52-week low of $5.97.To find similar research reports that are available for free follow the link below and sign up at www.StockPublisher.comDisclosure:StockPublisher.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, forcomplete risks and disclosures. Contact:Info@stockpublisher.com433plaza real Suite 275BocaRaton, Fl, 33432561-372-8342
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here